A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: Implications for new approaches in harm reduction and care

International Journal of Drug Policy

Volumn 23, Issue 1, 2012, Pages 33-36

  Gervasoni, Jean Pierre ^a   Balthasar, Hugues ^a   Huissoud, Thérèse ^a   Jeannin, André ^a   Dubois Arber, Françoise ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Harm reduction; Low threshold facilities; Methadone; Needle exchange programmes; Switzerland

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HARM REDUCTION; HEALTH STATUS; HEPATITIS C; HOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INTEGRATION; INTRAVENOUS DRUG ABUSE; MALE; METHADONE TREATMENT; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEX DIFFERENCE; SWITZERLAND;

ADULT; AGE FACTORS; COCAINE; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HIV SEROPOSITIVITY; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; NEEDLE-EXCHANGE PROGRAMS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; POPULATION SURVEILLANCE; SEX CHARACTERISTICS; SUBSTANCE ABUSE, INTRAVENOUS; SWITZERLAND;

EID: 82655181997     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2011.05.015     Document Type: Article

References (25)

1. Balthasar H., Huissoud T., Zobel F., Arnaud S., Samitca S., Jeannin A., et al. Evolution de la consommation et des pratiques à risques de transmission du VIH et du VHC chez les consommateurs de drogue par injection en Suisse, 1993-2006. Bulletin de l'Office Fédéral de la Santé Publique 2007, 45:804-809.
2. Benninghoff F. Prise en charge de la toxicodépendance en Suisse: une typologie des offres d'aide à 'bas seuil' et à 'haut seuil'. Santé, médecine et société: contributions à la sociologie de la santé 1999, 315-331. Seismo Verlag, Zurich. C. Maeder, C. Burton-Jeangros, M. Haour-Knipe (Eds.).
3. Benninghoff F., Morency P., Geense R., Huissoud T., Dubois-Arber F. Health trends among drug users attending needle exchange programmes in Switzerland (1994-2000). AIDS Care: Psychological and Socio-Medical Aspects of AIDS/HIV 2006, 18(4):371-375.
4. Committee on the Prevention of HIV Infection among Injecting Drug Users in High-risk Countries Preventing HIV infection among injecting drug users in high-risk countries. An assessment of the evidence 2006, The National Academies Press.
5. Dubois-Arber F., Balthasar H., Huissoud T., Zobel F., Arnaud S., Samitca S., et al. Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006. Euro Surveillance 2008, 13(21):1-6.
6. Dubois-Arber F., Jeannin A., Meystre-Agustoni G. Un système de surveillance de deuxième génération pour améliorer la surveillance du VIH/sida en Suisse. Bulletin de l'Office Fédéral de la Santé Publique 2006, 15:277-281.
7. Hagan H., McGough J.P., Thiede H., Hopkins S., Duchin J., Alexander E.R. Reduced injection frequency and increased entry and retention in drug treatment associated with needle exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 2000, 19(3):247-252.
8. Hedrich D. European report on drug consumption rooms 2004, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbonne.
9. Henderson L.A., Vlahov D., Celentano D.D., Strahtdee S.A. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. Journal of Acquired Immune Deficiency Syndromes 2003, 32(2):229-237.
10. Hosek M. Substitutionsbehandlungen in der Schweiz: Fortsetzung einer Erfolgsgeschichte. Suchtmagazin 2006, (1):3-9.
11. Kübler D., Wälti S. Drug policy-making in metropolitan areas: Urban conflicts and governance. International Journal of Urban and Regional Research 2001, 25(1):35-54.
12. Maag V. Estimated trends in the prevalence of heroin addiction in Switzerland: A multiple-indicator approach. European Addiction Research 2003, 9:176-181.
13. Mac Master S.A., Vail K.A. Demystifying the injection drug user: Willingness to participate in traditional drug treatment services among participants in a needle exchange program. Journal of Psychoactive Drugs 2002, 34(3):289-294.
14. Riley E.D., Safaeian M., Strathdee S.A., Beilenson P., Vlahov D. Drug treatment referrals and entry among participants of a needle exchange program. Substance Use and Misuse 2002, 37(14):1869-1886.
15. Schorr D., Künzi U. Was sagt uns die methadonstatistik über die Entwicklung der letzten Jahre? Ein Vergleich zwischen ausgewählten Kantonen. Abhängigkeiten 2007, (3).
16. Spreyermann C., Willen C. Analyse der Tätigkeiten und Angebotsbereiche in Anlaufstellen 2003, Sfinx, Bern.
17. Swiss Society of Addiction Medicine Substitution-assisted treatment in opioid dependence. Summary of the clinical recommendations for Substitution-assisted treatment (SAT) in opioid dependence issued by the SSAM (Swiss Society of Addiction Medicine) in 2007 2010, Federal Office of Public Health, Bern.
18. Toufik A., Cadet-Taïrou A., Janssen E., Gandilhon M. Première enquête nationale sur les usagers des CAARUD. Tendances 2008, 61:1-4.
19. Uchtenhagen A. Harm reduction: The case of Switzerland. European Addiction Research 1995, 1:86-91.
20. Valenciano M., Emmanuelli J., Lert F. Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction 2001, 96(4):597-606.
21. van den Berg C.H., Smit C., van Brussel G., Coutinho R., Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007, 102(9):1454-1462.
22. Wood E., Tyndall M., Qui Z., Zhang R., Montaner J., Kerr T. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injection facility. American Journal of Public Health 2006, 96(5):770-773.
23. Wood E., Tyndall M.W., Li K., Lloyd-Smith E., Small W., Montaner J.S., et al. Do supervised injecting facilities attract higher-risk injection drug users?. American Journal of Preventive Medicine 2005, 29(2):126-130. 10.1016/j.amepre.2005.04.011.
24. Wood E., Tyndall M.W., Montaner J.S., Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ: Canadian Medical Association Journal=Journal de l'Association Médicale Canadienne 2006, 175(11):1399-1404. 10.1503/cmaj.060863.
25. Zobel F., Thomas R., Arnaud S., De Preux E., Ramstein T., Spencer B., et al. Evaluation of the Confederation's measures to reduce drug-related problems: Fourth synthesis report 1999-2002 2003, Institut universitaire de médecine sociale et préventive, Lausanne.